The vertical excitation energies of H(2)TPP [TPP = 5,10,15,20-tetraphenylporphyrin(2-)], H(2)FcPh(3)P [FcPh(3)P = 5-ferrocenyl-10,15,20-triphenylporphyrin(2-)], cis-H(2)Fc(2)Ph(2)P [cis-Fc(2)Ph(2)P = 5,10-bisferrocenyl-15,20-diphenylporphyrin (2-)], trans-H(2)Fc(2)Ph(2)P [trans-Fc(2)Ph(2)P = 5,15-bisferrocenyl-10,20-diphenylporphyrin(2-)], H(2)Fc(3)PhP [H(2)Fc(3)PhP = 5,10,15-trisferrocenyl-20-phenylporphyrin(2-)], and H(2)TFcP [TFcP = 5,10,15,20-tetraferrocenylporphyrin(2-)] were investigated using a time-dependent density functional theory (DFT) approach and compared to their experimental UV-vis spectra in the 10,000-30,000 cm(-1) region. It was shown that the lowest energy transitions in meso(ferrocenyl)-containing porphyrins have predominantly ferrocene-to-porphyrin charge transfer character, while the porphyrin-centered π-π* transitions predicted by the Gouterman's classic four-orbital model still have the largest intensities in the UV-vis region. The number of predominantly ferrocene-to-porphyrin charge transfer transitions increases with the number of ferrocene substituents and becomes dominant in H(2)TFcP.
No takes yet. Share an insight, caveat, or question.
Nemykin et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: